Home / ErbB2/Her2 / Human ErbB2/Her2 Antibody

Human ErbB2/Her2 Antibody

Catalog #: AF1129
18 Citations Datasheet
Catalog # Availability Size / Price Qty
AF1129
AF1129-SP
ErbB2/Her2 in Human Breast Cancer Tissue.
1 Image
Product Details
Citations (18)
FAQs
Supplemental Products
Reviews
Summary Data Examples Preparation and Storage Reconstitution Calculator Background Product Datasheets Related Research Areas

Human ErbB2/Her2 Antibody Summary

Species Reactivity
Human
Specificity
Detects human ErbB2/Her2 in direct ELISAs and Western blots. In direct ELISAs, less than 20% cross-reactivity with recombinant mouse ErbB2 is observed and less than 5% cross-reactivity with recombinant human (rh) ErbB3, rhErbB4, and rhEGF R is observed.
Source
Polyclonal Goat IgG
Purification
Antigen Affinity-purified
Immunogen
Mouse myeloma cell line NS0-derived recombinant human ErbB2/Her2
Thr23-Thr652
Accession # P04626
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
Endotoxin Level
<0.10 EU per 1 μg of the antibody by the LAL method.
Label
Unconjugated

Applications

Recommended Concentration
Sample
Western Blot
0.1 µg/mL
Recombinant Human ErbB2/Her2 Fc Chimera (Catalog # 1129-ER)
Flow Cytometry
2.5 µg/106 cells
MCF‑7 human breast cancer cell line
Immunohistochemistry
5-15 µg/mL
See below
CyTOF-ready
Ready to be labeled using established conjugation methods. No BSA or other carrier proteins that could interfere with conjugation.
 
Inhibition of Cell Growth
Measured by its ability to inhibit proliferation in the SK‑BR‑3 human breast cancer cell line. Brodowicz, T. et al. (1997) Int. J. Cancer 73:875. The ED50 for this effect is typically 0.06-0.3 µg/mL.
 

Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.

Scientific Data

Immunohistochemistry ErbB2/Her2 antibody in Human Breast Cancer Tissue by Immunohistochemistry (IHC-P). View Larger

ErbB2/Her2 in Human Breast Cancer Tissue. ErbB2/Her2 was detected in immersion fixed paraffin-embedded sections of human breast cancer tissue using Goat Anti-Human ErbB2/Her2 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF1129) at 1.7 µg/mL overnight at 4 °C. Tissue was stained using the Anti-Goat HRP-DAB Cell & Tissue Staining Kit (brown; Catalog # CTS008) and counterstained with hematoxylin (blue). Specific staining was localized to epithelial cells. View our protocol for Chromogenic IHC Staining of Paraffin-embedded Tissue Sections.

Preparation and Storage

Reconstitution
Reconstitute at 0.2 mg/mL in sterile PBS.
Loading...
Shipping
Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: ErbB2/Her2

ErbB2, also called Neu and Her2 (human epidermal growth factor receptor 2), is a type I membrane glycoprotein that is a member of the ErbB family of tyrosine kinase receptors. ErbB family members serve as receptors for the epidermal growth factor (EGF) family of growth factors. ErbB2 is widely expressed in epithelial cells and has also been found to be over-expressed in a large number of breast carcinomas. Among ErbB family members, ErbB2 is unique in that it has no identified ligands. Rather, ErbB2 heterodimerizes with the other members of the ErbB family (ErbB1 (EGFR), ErbB3, ErbB4) to form higher affinity signaling complexes. Because ErbB3 contains a defective kinase domain, the kinase domain of ErbB2 is responsible for initiating the tyrosine phosphorylation signal through the heterodimeric receptor. It has been found that a discrete three amino acid signal in the ErbB3 cytoplasmic domain is critical for transactivation of ErbB2. Interestingly, this same three amino acid signal has also been found in ErbB1 and ErbB4. Phosphoinositide 3-kinase has been shown to play a role in ErbB2 signal transduction. The cytoplasmic domain of ErbB2 has been shown to associate with beta-catenin and plakoglobin. Human ErbB2 consists of 1255 amino acids (aa) with a 21 aa signal sequence, a 631 aa extracellular domain, a 23 aa transmembrane region, and a 580 aa cytoplasmic domain. ErbB2 can be shed from the cell surface by proteolytic cleavage by an unidentified protease. ErbB2 appears to play roles in development, cancer, communication at the neuromuscular junction, and regulation of cell growth and differentiation (1-10).

References
  1. Coussens, L. et. al. (1985) Science 230:1132.
  2. Yamamoto, T. et. al. (1986) Nature 319:230.
  3. Kanai, Y. et. al. (1995) Biochem. Biophys. Res. Commun. 208:1067.
  4. Codony-Servat, J. et. al. (1999) Cancer Res. 59:1196.
  5. Carraway, K.L. 3rd et. al.  (1994) J. Biol. Chem. 269:14303.
  6. Emkey, R. and C.R. Kahn (1997) J. Biol. Chem. 272:31172.
  7. Schaefer, G. et. al. (1999) J. Biol. Chem. 274:859.
  8. Schlessinger, J. (2000) Cell 103:211.
  9. Hellyer, N.J. et. al. (2001) J. Biol. Chem. 276:42153.
  10. Daly, R.J. (1999) Growth Factors 16:255.
Long Name
Receptor Tyrosine Protein Kinase ErbB2
Entrez Gene IDs
2064 (Human); 13866 (Mouse); 24337 (Rat); 102146608 (Cynomolgus Monkey)
Alternate Names
CD340 antigen; CD340; c-erb B2/neu protein; EC 2.7.10; EGFR2; ErbB2; HER2; HER-2; HER2EC 2.7.10.1; herstatin; Metastatic lymph node gene 19 protein; MLN 19; MLN19; Neu Oncogene; NEUHER-2/neu; neuroblastoma/glioblastoma derived oncogene homolog; NGL; NGLTKR1; p185erbB2; Proto-oncogene c-ErbB-2; Proto-oncogene Neu; receptor tyrosine-protein kinase erbB-2; TKR1; Tyrosine kinase-type cell surface receptor HER2; v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2(neuro/glioblastoma derived oncogene homolog); v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastomaderived oncogene homolog (avian)

Product Datasheets

You must select a language.

x
Product Datasheet

Citations for Human ErbB2/Her2 Antibody

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

18 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. Direct protein quantification in complex sample solutions by surface-engineered nanorod probes
    Authors: S Schrittwie, B Pelaz, WJ Parak, S Lentijo-Mo, K Soulantica, J Dieckhoff, F Ludwig, J Schotter
    Sci Rep, 2017-07-06;7(1):4752.
  2. Development of Electrochemical Immunosensors for HER-1 and HER-2 Analysis in Serum for Breast Cancer Patients
    Authors: S Wignarajah, I Chianella, IE Tothill
    Biosensors, 2023-03-07;13(3):.
    Species: Human
    Sample Types: Protein
    Applications: ELISA Capture
  3. Cell surface protein aggregation triggers endocytosis to maintain plasma membrane proteostasis
    Authors: Paul D, Stern O, Vallis Y et al.
    Nature communications
  4. Multiomic Profiling Identified EGF Receptor Signaling as a Potential Inhibitor of Type I Interferon Response in Models of Oncolytic Therapy by Vesicular Stomatitis Virus
    Authors: AS Nikitina, AV Lipatova, AO Goncharov, AA Kliuchniko, MA Pyatnitski, KG Kuznetsova, A Hamad, PO Vorobyev, ON Alekseeva, M Mahmoud, Y Shakiba, KS Anufrieva, GP Arapidi, MV Ivanov, IA Tarasova, MV Gorshkov, PM Chumakov, SA Moshkovski
    International Journal of Molecular Sciences, 2022-05-08;23(9):.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  5. CHIP/STUB1 Ubiquitin Ligase Functions as a Negative Regulator of ErbB2 by Promoting Its Early Post-Biosynthesis Degradation
    Authors: H Luan, TA Bailey, RJ Clubb, BC Mohapatra, AM Bhat, S Chakrabort, N Islam, I Mushtaq, MD Storck, SM Raja, V Band, H Band
    Cancers, 2021-08-04;13(16):.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  6. Cellphone enabled point-of-care assessment of breast tumor cytology and molecular HER2 expression from fine-needle aspirates
    Authors: Daniel Y. Joh, Jacob T. Heggestad, Shengwei Zhang, Gray R. Anderson, Jayanta Bhattacharyya, Suzanne E. Wardell et al.
    npj Breast Cancer
  7. Immunomagnetic sequential ultrafiltration (iSUF) platform for enrichment and purification of extracellular vesicles from biofluids
    Authors: J Zhang, LTH Nguyen, R Hickey, N Walters, X Wang, KJ Kwak, LJ Lee, AF Palmer, E Reátegui
    Scientific Reports, 2021-04-13;11(1):8034.
    Species: Human
    Sample Types: Whole Cells
    Applications: Flow Cytometry, ICC
  8. The deubiquitylase USP2 maintains ErbB2 abundance via counteracting endocytic degradation and represents a therapeutic target in ErbB2-positive breast cancer
    Authors: J Zhang, S Liu, Q Li, Y Shi, Y Wu, F Liu, S Wang, MY Zaky, W Yousuf, Q Sun, D Guo, T Wang, Y Zhang, Y Wang, M Li, H Liu
    Cell Death Differ., 2020-04-23;0(0):.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Immunoprecipitation
  9. Stable and Potent Selenomab-Drug Conjugates
    Authors: X Li, CG Nelson, RR Nair, L Hazlehurst, T Moroni, P Martinez-A, AR Nanna, D Hymel, TR Burke, C Rader
    Cell Chem Biol, 2017-03-16;24(4):433-442.e6.
    Species: Human
    Sample Types: Whole Cells
    Applications: Flow Cytometry
  10. Marked enhancement of lysosomal targeting and efficacy of ErbB2-targeted drug delivery by HSP90 inhibition
    Authors: Srikumar M. Raja, Swapnil S. Desale, Bhopal Mohapatra, Haitao Luan, Kruti Soni, Jinjin Zhang et al.
    Oncotarget
  11. Polypeptide-based nanogels co-encapsulating a synergistic combination of doxorubicin with 17-AAG show potent anti-tumor activity in ErbB2-driven breast cancer models
    Authors: Swapnil S. Desale, Srikumar M. Raja, Jong Oh Kim, Bhopal Mohapatra, Kruti S. Soni, Haitao Luan et al.
    Journal of Controlled Release
  12. Engineering a single ubiquitin ligase for the selective degradation of all activated ErbB receptor tyrosine kinases.
    Authors: Kong F, Zhang J, Li Y, Hao X, Ren X, Li H, Zhou P
    Oncogene, 2013-02-18;33(8):986-95.
    Species: Human
    Sample Types: Whole Cells
    Applications: Flow Cytometry
  13. Protein tag-mediated conjugation of oligonucleotides to recombinant affinity binders for proximity ligation
    Authors: Gucci Jijuan Gu, Mikaela Friedman, Christian Jost, Kai Johnsson, Masood Kamali-Moghaddam, Andreas Plückthun et al.
    New Biotechnology
  14. ErbB2 Is Necessary for ErbB4 Ligands to Stimulate Oncogenic Activities in Models of Human Breast Cancer
    Authors: Christopher P Mill, Michael D Zordan, S Michael Rothenberg, Jeffrey Settleman, James F Leary, David J Riese
    Genes & Cancer
  15. Novel method for differentiation between Trastuzumab and host adaptive response.
    Authors: Denisova G, Jenkins K, Evelegh C, Bramson J
    Mol. Immunol., 2011-06-08;48(15):1882-5.
    Species: Human
    Sample Types: Recombinant Protein
    Applications: Western Blot
  16. Human epidermal growth factor receptor (HER-1:HER-3) Fc-mediated heterodimer has broad antiproliferative activity in vitro and in human tumor xenografts.
    Authors: Sarup J, Jin P, Turin L, Bai X, Beryt M, Brdlik C, Higaki JN, Jorgensen B, Lau FW, Lindley P, Liu J, Ni I, Rozzelle J, Kumari R, Watson SA, Zhang J, Shepard HM
    Mol. Cancer Ther., 2008-10-01;7(10):3223-36.
    Species: Human
    Sample Types: Cell Lysates, Recombinant Protein
    Applications: ELISA Development, Western Blot
  17. FGFR2-amplified gastric cancer cell lines require FGFR2 and Erbb3 signaling for growth and survival.
    Authors: Kunii K, Davis L, Gorenstein J, Hatch H, Yashiro M, Di Bacco A, Elbi C, Lutterbach B
    Cancer Res., 2008-04-01;68(7):2340-8.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Immunoprecipitation, Western Blot
  18. NRG1 and KITL signal downstream of retinoic acid in the germline to support soma-free syncytial growth of differentiating spermatogonia.
    Authors: Chapman KM, Medrano GA, Chaudhary J, Hamra FK.
    Cell Death Discov.

FAQs

No product specific FAQs exist for this product, however you may

View all Antibody FAQs
Loading...

Reviews for Human ErbB2/Her2 Antibody

There are currently no reviews for this product. Be the first to review Human ErbB2/Her2 Antibody and earn rewards!

Have you used Human ErbB2/Her2 Antibody?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review